drugset / Trial / NCT00419718

Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes

NCT00419718

Phase 1 Completed 23 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

The trial is conducted in Europe. This clinical pharmacology trial investigates the effect of exercise on the pharmacokinetics and pharmacodynamics of inhaled insulin in subjects with type 1 diabetes.

Timeline

Start
2005-10
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 0.19 iu/kg Inhaled